Promising chordoma-specific immunotherapy trial now open at two sites
Launched last spring, a Phase 1 clinical trial studying the safety and initial effectiveness of the immunotherapy drug nivolumab with and … Continue reading
Category Archives: Clinical Research
Enrollment temporarily suspended for Epizyme’s tazemetostat trial
On Monday, April 23, the United States Food and Drug Administration (FDA) issued a temporary clinical hold, meaning a pause … Continue reading
Accelerating drug therapies from the bench to the clinic
Thanks to the robust scientific infrastructure built by the Chordoma Foundation over the last decade, chordoma research is thriving. With … Continue reading
New clinical trial opens testing targeted cancer therapy, palbociclib
A new clinical trial has opened for chordoma patients with locally advanced or metastatic tumors testing the effectiveness of a … Continue reading
An experimental treatment changed the life of a courageous young chordoma survivor
As the youngest child in a family of California dairy farmers, Frankie Fernandes was used to waking up early. But … Continue reading
Now open: immunotherapy research study designed specifically for chordoma patients
Nivolumab + stereotactic radiosurgery A new clinical trial has opened for chordoma patients with advanced or metastatic tumors testing a … Continue reading
New clinical trial options available for chordoma patients
Introducing a new treatment pathway for patients with advanced or recurrent chordoma Historically, treatment options for patients with residual, recurrent, … Continue reading
New clinical trial opens for patients with dedifferentiated chordoma
Chordoma patients with particularly aggressive and fast growing tumors may have a new treatment option: a recently opened clinical trial … Continue reading
CF meets $300,000 funding goal for new clinical trial
I am thrilled to announce that we have reached the goal we set in December to raise the $300,000 needed to … Continue reading
National Cancer Institute opens first therapeutic vaccine trial for chordoma patients
The National Cancer Institute has expanded an ongoing Phase I clinical trial of a therapeutic vaccine targeting the brachyury protein … Continue reading